BACE1 and Cognitive impairment: Studies have shown that the activity of BACE1 is significantly elevated in the brain tissue (16, 17) and cerebrospinal fluid (CSF) (13) of patients suffering from mild cognitive impairment and sporadic Alzheimer’s disease.